Table 1 Characteristics of all patients
Characteristic | T + C (n = 50) | T (n = 67) | p |
|---|---|---|---|
Age (years) | Â | Â | 0.294 |
 Median (range) | 59(36–81) | 61(40–84) |  |
Sex | Â | Â | 0.506 |
 Male | 24(48.00%) | 28(38.27%) |  |
 Female | 26(52.00%) | 39(61.73%) |  |
Histology | Â | Â | 1.000 |
 Adenocarcinoma | 50(100.00%) | 67(100.00%) |  |
ECOG PS | Â | Â | 0.835 |
 0–1 | 49(98.00%) | 66(98.77%) |  |
 2 | 1(2.00%) | 1(1.23%) |  |
Smoking history | Â | Â | 0.986 |
 Nerve | 35(70.00%) | 47(72.84%) |  |
 Former | 15(30.00%) | 20(27.16%) |  |
EGFR mutation | Â | Â | 0.321 |
 Exon 19 deletion | 26(52.00%) | 41(55.56%) |  |
 L858R | 21(42.00%) | 23(38.27%) |  |
 Others | 3(8.00%) | 3(6.17%) |  |
Brain metastasis | Â | Â | 0.345 |
 Yes | 9(18.00%) | 17(23.46%) |  |
 No | 41(82.00%) | 50(76.54%) |  |
Stage | Â | Â | 0.713 |
 IIIb/IIIc | 3(6.00%) | 3(3.70%) |  |
 IV | 47(94.00%) | 64(96.30%) |  |
Cardiovascular | Â | Â | Â |
 Hypertension | 15(30.00%) | 21(31.34%) | 0.877 |
 Coronary heart disease | 0(0.00%) | 1(1.23%) | 0.388 |
 Cerebrovascular disease | 0(0.00%) | 2(2.99%) | 0.220 |
Metabolic | Â | Â | Â |
 Diabetes | 6(12.00%) | 6(8.96%) | 0.593 |
 Hyperlipidemia | 2(4.00%) | 1(1.23%) | 0.398 |
 Hyperuricemia | 0(0.00%) | 1(1.23%) | 0.388 |